GlassScriptPhysician profile
Linsay A Angus
NPI 1770147415
$9,533.36
in general payments reported to CMS, 2019-2025
35 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,626 · 2022: $3,124 · 2023: $1,695 · 2024: $1,876 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,718 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,718.19 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,694.59 | 2021-2022 | |
| Amgen INC. | $956.03 | 2021-2024 | Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $595.72 | 2021-2024 | Eliquis, Camzyos |
| Lilly USA, LLC | $573.89 | 2021-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $549.99 | 2021-2024 | Farxiga, Atacand |
| Novo Nordisk INC | $535.09 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $485.33 | 2021-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $446.08 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $418.28 | 2021-2022 | |
| Pfizer INC. | $398.06 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $265.98 | 2022-2024 | |
| Glaxosmithkline, LLC. | $251.78 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $246.85 | 2023-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.03 | 2023-2025 | Lifevest |
| Biohaven Pharmaceutical Holding Company LTD. | $226.94 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $200.62 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Inari Medical, INC. | $175.29 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scpharmaceuticals INC. | $174.56 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $168.68 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $156.20 | 2023-2025 | Watchman Flx, Watchman Access System, Watchman |
| Esperion Therapeutics, INC. | $131.09 | 2021-2024 | Nexletol |
| Impel Pharmaceuticals INC. | $113.40 | 2023 | Trudhesa |
| Actelion Pharmaceuticals US, INC. | $84.30 | 2023-2024 | Opsumit, Uptravi |
| Vifor Pharma, INC. | $69.11 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $66.16 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $61.75 | 2021 | |
| Amarin Pharma, INC. | $47.54 | 2022 | |
| Astellas Pharma US INC | $46.95 | 2021-2023 | Lexiscan |
| Abbott Laboratories | $45.63 | 2024 | Supera, Infinity |
| Medicomp INC | $23.14 | 2023 | Telepatch Cardiac Monitor |
| Allergan, INC. | $19.20 | 2022 | |
| Watermark Medical, INC. | $18.40 | 2025 | |
| Daiichi Sankyo INC. | $18.22 | 2022 | |
| Bridgebio Pharma, INC. | $17.11 | 2025 | Attruby |
| Baxter Healthcare | $14.37 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linsay Angus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.